Gilead Sciences, Inc.Foster City, California, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
120 - Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
Thursday, October 12, 202312:35 PM – 12:40 PM US ET
